When newborn babies suffer from respiratory failure, inhaling nitric oxide can help them breathe easier. Third Pole Therapeutics Founder Dr. Warren Zapol invented the treatment, and over the next two decades, built it into a scalable technology that has benefited hundreds of thousands of pediatric and adult patients alike.

The company is at the leading edge of a $600 million inhaled nitric oxide market, as its technology solves the cost and logistical hurdles of systems that use compressed gas cylinders.

Third Pole Therapeutics' two novel platforms include eNOfit™, a miniaturized wearable device for home and travel, and eNOcare™, a lightweight portable in-hospital device. Both generate inhaled nitric oxide by combining electricity and the air we breathe, creating a "make it and take it" therapy, free from the hazards of compressed gas storage.